Adopting a modern liquid chromatography (LC) technology in a global economy is driven by a few factors. In a highly competitive and regulated environment, there is a need to lower costs without compromising product quality while maintaining regulatory and compliance requirements. Along with this competition are considerations of increased profitability. Investing in the correct LC technologies can help you deliver a sustainable competitive advantage.

Waters present various strategies to reduce carryover in the flow path following the use of different injector systems and configurations. In the example of multi-mycotoxin methods, Waters’ ACQUITY Premier and columns significantly reduced carryover of Fumonisins by 80% compared to conventional UHPLC systems. This allowed for the removal of metal chelators in the mobile phase and needle wash solutions, improving the overall analytical throughput.